GlassScriptPhysician profile
J B Joo
NPI 1558337089
$11,071.64
in general payments reported to CMS, 2019-2025
12 companies · $28.15 in 2025
The $28.15 reported for 2025 was less than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $450 · 2020: $9,786 · 2021: $20.24 · 2022: $400 · 2023: $359 · 2024: $28.36 · 2025: $28.15.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $416.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $415.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $9,875.67 | 2019-2022 | |
| Davol INC. | $270.03 | 2019-2022 | |
| Medtronic, INC. | $143.25 | 2023 | Signet |
| Stryker Corporation | $138.89 | 2019 | |
| Allergan, INC. | $131.31 | 2019 | |
| Braintree Laboratories, INC. | $115.34 | 2019-2024 | Suflave |
| Axonics, INC. | $105.26 | 2023 | Axonics |
| Baxter Healthcare | $99.34 | 2022 | |
| Kci USA, INC. | $72.73 | 2023 | Abthera Advance |
| Conmed Corporation | $71.43 | 2022 | |
| Abbvie INC. | $28.15 | 2025 | |
| Ethicon US, LLC | $20.24 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw J Joo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.